Hosted on MSN10mon
Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response
Traditionally, therapies combining DNA-damaging agents and STING agonists have shown potential in treating cancer by enhancing immune response and reshaping the tumor microenvironment. However ...
BioWorld8d
STING agonist promotes long-term remission in bladder cancer models
The standard treatment for non-muscle invasive bladder cancer (NMIBC) is Bacillus Calmette-Guérin (BCG). However, despite it being effective, many patients experience recurrences, and others become ...
pharmaphorum1y
Mersana stung by FDA hold on STING drug
The fatality is considered to be related to the drug treatment, according to the biotech, which is developing the STING agonist in collaboration with GSK under the terms of a $1.3 billion option ...
BioWorld1mon
Polypid brings PLEX technology to STING agonist collaboration with Immunogenesis
technology and Immunogenesis’ potent STING agonist drug candidate to potentially enhance treatment for solid tumors.
Asian News International10mon
Curadev Announces First Treatment Cycle Completion for the First Patient Dosed in a Phase 1a/b Clinical Trial of Allosteric STING Agonist CRD3874-SI
Adani places India's largest order for 8 tugs under Make in India initiative for 450 cr with Cochin shipyard ...